ICR forms collaboration with AI drug discovery company to develop new possible treatments in rare ch

Scientists at The Institute of Cancer Research, London, are working with Healx, a biotech company specialising in artificial intelligence (AI) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), an essentially untreatable brain cancer in children.

Read more: https://www.icr.ac.uk/news-archive/icr-forms-collaboration-with-ai-drug-discovery-company-to-develop-new-possible-treatments-in-rare-childhood-cancer-dipg